Posted: January 30th, 2017 | Author: DoseSpot | Filed under: Basics, Public Policy | Tags: e-Prescribing, e-Prescribing Platform, e-Prescribing Registration, e-Prescribing Software, e-Prescribing Solution, e-Prescribing State Mandates, New York e-Prescribing Mandate, New York e-Prescribing Registration, New York e-Prescribing Renewal, New York e-Prescribing Vendor Registration, New York e-Prescribing Vendor Renewal, New York Mandate, New York State Dental Association, New York State Department of Health, New York State Mandate, Registration for Official Prescriptions and e-Prescribing Systems, ROPES, State Mandates | No Comments »
If you are a prescriber in the state of New York, you probably know by now that electronic prescribing (e-Prescribing) of both controlled and non-controlled substances has been mandatory since March 27, 2016. As part of this mandate, all prescribers who will be sending controlled substances are required to register their e-Prescribing software as well as report to the controlled drug registry each time a controlled medication is prescribed or dispensed. In order for users to access the registry, the prescriber must first create an online Health Commerce System (HCS) account. Once the HCS account is active, the prescriber can then access ROPES to register their certified electronic prescribing software application for controlled substances.
The good news is that applying for an HCS account is as easy as filling out an online form and having a New York State driver’s license (or photo ID).
Applying for an HCS Account
Requirements: New York state valid driver’s license or photo ID and New York State Education Department registered medical professional license
To apply, you will need to access the following page: https://apps.health.ny.gov/pub/top.html
After you have applied and have been granted an HCS account, you will be able to sign back in via this link: https://commerce.health.state.ny.us
You may also use the following link as a reference to see in full detail a direct guide of the application process: https://apps.health.ny.gov/pub/ctrldocs/paperless_docp.pdf
In addition to requiring an account in the Health Commerce System (HCS), if prescribers intend to order controlled substances electronically, they will also need to register their certified electronic prescribing application software with the New York State Department of Health, Bureau of Narcotic Enforcement (BNE). This is done by filling out a ROPES form online through an HCS account.
What is a ROPES form?
A ROPES form is a new online application that allows the practitioner/organization to renew their registration for the Official Prescription Program and register their certified electronic prescribing software application for controlled substances. ROPES stands for Registration for Official Prescriptions and E-prescribing Systems. Only the prescriber can access the ROPES application.
Pre-requisite Requirements for ROPES
- Prescriber must be already registered with the Official Prescription Program (OPP)
- Prescriber must have an active DEA registration
- Prescriber must have an active NY license
- Prescriber must NOT be a registered Physician Assistant (PA) – PA’s must continue to submit the OPP registration form (DOH-4329) along with the PA Authorization Form (DOH-5054) to renew their OPP registration.
Completing the ROPES Form
In order for a prescriber to fill out a ROPES form, he/she must log into his/her HCS account (outlined above) by accessing the following weblink: https://commerce.health.state.ny.us and following the next few steps:
- Select “my content†at the top of the page
- Scroll down and select “All applicationsâ€
- Scroll over and select “Râ€
- Scroll down and select “ROPES†and complete the form
The ROPES form requires that the prescriber identifies the third party audit certifying organization and the date of the third party audit. Keep in mind that it is the software vendor that must be certified not the prescriber. The software vendor will supply all necessary information about this certification to the prescriber. The ROPES form must be renewed every two (2) years in order to remain valid. The prescriber must renew their OPP registration first via the one step process prior to renewing their current ROPES registration.
Questions?
Any questions regarding the ROPES form or the process can be directed to the BNE at narcotic@health.state.ny.us or by calling 1-866-811-7957.
For prescribers utilizing DoseSpot who have questions regarding the ROPES required third party audit information, please contact DoseSpot support at 888-847-6814.
Author: Shannon K.
Sources: Practice Fusion; New York State Dental Association; New York State Department of Health
About DoseSpot
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: August 2nd, 2016 | Author: Shauna | Filed under: Basics, Controlled Substances, In the News | Tags: Controlled Substances, e-Prescribing, EHR, EHR software, electronic prescribing, I-STOP, Legislation, Maine State Mandate, Minnesota State Mandate, New York State Mandate, Opioid Epidemic, Opioids, PDMPs, Prescription Drug Monitoring Programs, Schedule II, State Mandates, USA Today | No Comments »
With a nationwide opioid epidemic upon us, states are starting to insist that prescribers conduct a bit of research before writing prescriptions for addictive medications like pain medications or benzodiazepines. States have therefore created statewide Prescription Drug Monitoring Programs (PDMPs) to monitor an individuals’ controlled substance dispense trends which are meant to assist a prescriber in making smarter treatment decisions. The goal here is to check a patient’s medication history to determine if the patient is doctor shopping or if they may have potential complications with medication(s) they are taking or have taken. Ultimately, PDMPs aid a prescriber in understanding the risks involved in prescribing these powerful medications for their patients.
“Databases known as Prescription Drug Monitoring Programs show doctors all controlled-substance prescriptions patients get and should be linked with the electronic health records (EHRs) that allow doctors to e-Prescribe.†USA Today
In most states, healthcare professionals who prescribe at least one controlled substance are encouraged, not required, to use PDMPs. The USA Today article addresses the fact that only five states promote the use of PDMPs and less than 20% of doctors use the databases when it isn’t required. On the other hand, e-Prescribing of controlled substances has proven to be an effective tool in combating this crisis, yet only three states have mandated the use of e-Prescribing, and one doesn’t enforce its own law.
Click here to learn more about e-Prescribing and how to stay ahead of this opioid crisis
All 50 States (and D.C) have now passed legislation allowing the e-Prescribing of both controlled and non-controlled substances, which is a drastic change from only a few years ago with federal regulations prohibiting the e-Prescribing of controlled substances.
Let’s take a look at the states that have mandated e-Prescribing:
New York: The first state to mandate and enforce its e-Prescribing laws as of March 2016, New York requires prescribers to check their state PDMP database and prescribers who continue to write paper prescriptions are subject to fines, jail time, or both. Since implementing, total numbers of opioid analgesics prescribed fell by 78%.
Minnesota: Technically the first state to deploy mandatory e-Prescribing, they currently do not enforce the use of such technology. The MN Department of Health recently reported that drug overdose deaths jumped 11% between 2014 and 2015 and more than half were related to prescription drugs, specifically opioid pain relievers, rather than illegal street drugs. Minnesota Health Commissioner Dr. Ed Ehlinger said, “The new data show the need for a broader approach to addressing the root causes of drug addiction and overdoses.†Stay tuned.
Maine: Experiencing one of the highest death rates in the country due to opioid overdose, Maine recently mandated e-Prescribing for schedule II controlled substances and will be put into effect come June 2017. Similar to New York, prescribers will face fines, jail time, or both if they choose to utilize paper prescription pads.
New Jersey is also on the horizon to mandate e-Prescribing in due time. As a collective nation, we can no longer sit back and overlook the link between opioid overprescribing and opioid overdose. E-Prescribing and PDMPs should work hand in hand; the benefits are exceedingly visible and with 3-9% of opioid abusers using forged written prescriptions, it’s a commonsense solution. Protect your company, protect your providers, but more importantly, protect your patients. They depend on it.
About DoseSpot
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit http://www.DoseSpot.com.
Posted: July 13th, 2016 | Author: Shauna | Filed under: Basics, Controlled Substances, Dental, In the News, Public Policy, Security | Tags: Congress, Controlled Substances, Dental, Dental e-Prescribing, DoseSpot, e-Prescribing, e-Prescribing controlled substances, iSTOP, New York State Mandate, Opioid Epidemic, Opioid Prescriptions, Opioids, PDMP, Prescription Drug Monitoring Programs, State Mandates | No Comments »
As the opioid epidemic continues and more policies have recently been implemented to curb this crisis, it seems that a crucial piece of the puzzle is missing: mandatory electronic prescribing. Like Devon Herrick mentions in his latest post, e-Prescribing is a commonsense solution for an issue that isn’t slowing down in the United States. Now is the time for Congress to step up and take advantage of solutions that are not only available, but approved and certified by the DEA. It’s clear that efforts to prevent and treat the opioid epidemic will fall short without additional investments and while states have implemented Prescription Drug Monitoring Programs (PDMPs), they’re not mandatory and the ability to further capture data will undoubtedly be a pivotal cornerstone while facing this epidemic and for several reasons. With electronic prescribing:
- A prescriber can track a patient’s medication history and make smarter treatment decisions, i.e. doctor shopping, recent prescriptions filled, and drug-to-drug and drug-to-allergy interactions.
- There is no more need for paper prescriptions, therefore no more interpreting messy handwriting, no more altered dispense quantities, and no more stolen prescription pads.
- Â A significant decline will occur relative to the rate of fraud, resale and abuse of opioids because e-Prescribing secures all information exchanges from diversion.
Electronic prescribing has been utilized by doctors for a few years now, but the e-Prescribing of controlled substances is last to hop on the bandwagon. Until recently, federal regulations prohibited e-prescribing of controlled substances due to perceived risks, however electronic prescribing diminishes these elements of risk.
Click here to learn more about e-Prescribing and start saving time and money today!
Since New York mandated that all prescriptions must be sent electronically, dentists in particular, have seen a vast change in the number of opioid prescriptions: “In a study of dentists, within a few months after iSTOP was implemented in New York, opioid prescriptions fell by about half, from 31 percent of dental visits before iSTOP to 14 percent in the following three months. The quantity of pills per prescription also fell. The total numbers of opioid analgesics prescribed fell by three-quarters (78 percent).”
Whether it’s mandated or not, the numbers don’t lie – electronic prescribing proves to be the smarter and safer force as we battle opioid addiction. Congress, take note.
Sources: National Center for Policy Analysis; PLOS; National Safety Council; NPR; Congress
About DoseSpot DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit http://www.DoseSpot.com.